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Rottlerin, a polyphenol isolated from Mallotus Philippinensis, has been recently used as a selective inhibitor of PKC δ, although
it can inhibit many kinases and has several biological eﬀects. Among them, we recently found that Rottlerin inhibits the Nuclear
FactorκB(NFκB),activatedbyeitherphorbolestersorH2O2.BecauseoftheredoxsensitivityofNFκBandonthebasisofRottlerin
antioxidant property, we hypothesized that Rottlerin could prevent NFκB activation acting as a free radicals scavenger, as other
natural polyphenols. The current study conﬁrms the antioxidant property of Rottlerin against the 2,2-diphenyl-1-picrylhydrazyl
radical (DPPH) in vitro and against oxidative stress induced by H2O2 and by menadione in culture cells. We also demonstrate that
Rottlerin prevents TNFα-dependent NFκB activation in MCF-7 cells and in HT-29 cells transfected with the NFκB-driven plasmid
pBIIX-LUC, suggesting that Rottlerin can inhibit NFκB via several pathways and in several cell types.
Copyright © 2009 Emanuela Maioli et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Rottlerin (also called mallotoxin or kamala) is a pigmen-
ted plant product isolated from MallotusPhilippinensis
(Figure 1), used in India in ancient times as a remedy for
tapeworm [1–3].
Since 1994, Rottlerin has been used as a PKCδ inhibitor
based on in vitro studies that have shown that the IC50 for
PKCδ was 3–6μM compared to 30–100μM for the other
PKC isozymes [4], although the selectivity of Rottlerin in
inhibiting PKC δ isoform has been recently questioned [5].
Several phloroglucinol derivatives, which are similar to
Rottlerin in structure, have been demonstrated to have
antiinﬂammatory and antiallergic properties [6, 7].
Moreover, Rottlerin can target mitochondria, interfering
in the respiratory chain as an uncoupler of oxidative
phosphorylation [8], and activates the large conductance
voltage and Ca++ activated K+ channel (BK) in human
vascular smooth muscle; its use has been patented (patent
WO/2006/060196)inthetherapyofhypertensionandrelated
disorders [9].
Our laboratory showed for the ﬁrst time that Rottlerin
can suppress NFκB activation induced by either phorbol
e s t e ro rH 2O2, in MCF-7 cells and in HaCaT keratinocytes,
respectively, in a PKC-independent way [10, 11]. Rottlerin
is a pleiotropic inhibitor, able to inhibit the activity of
a number of unrelated kinases, such as AKT/PKB and
calmodulin-dependent kinases (CaMKs) I-III [12, 13], two
known upstream mediators of the NFκBa c t i v a t i o np r o c e s s
[14–19].
Although the underlying molecular mechanisms have
not been yet investigated in details Rottlerin interference in
the NFκB activation process was likely achieved, in MCF-7
cells, through inhibition of CaMKII, without involvement of
the AKT/PKB pathway [10].
The transcription factor NFκB consists of p50 and p65
heterodimer, which is retained in the cytoplasm by masking










Figure 1: Chemical structure of Rottlerin.
Upon activation, IκBα kinase (IKK) phosphorylates IκBα,
promotes its ubiquitination and degradation, thus allowing
p50-p65 to translocate to the nucleus, bind to its consensus
sequence, and induce transcription of genes essential for
cell proliferation and survival [20]. Consistently, Rottlerin
inhibition of NFκB caused downregulation of cyclin D1 and
growth arrest in both MCF-7 and in HaCaT cells [10, 11].
Because NFκB can be activated by a number of signaling
molecules [21], we performed further experiments to sup-
port the idea that Rottlerin inhibits NFκBi nd i ﬀerent cell
types and under diﬀerent stimuli.
One interesting characteristic of NFκB is its extreme sen-
sitivity tocellularredox state[22]. Since many agents activat-
ing NFκB are modulated by Reactive Oxygen Species (ROS)
or by pro-oxidants, we wondered whether the inhibitory
eﬀects of Rottlerin, previously observed by us, could be
also due to its antioxidant potential. Rottlerin, indeed, is
a5,7-dihydroxy-2,2-dimethyl-6-(2,4,6-trihydroxy-3-methyl-
5-acetylbenzyl)-8-cinnamoyl-l,2-chromeneandcontainsﬁve
phenolic hydroxyl groups that might likely act as hydrogen
donors in the scavenging of free radicals in analogy with
other polyphenols with documented antioxidant properties.
An unexhaustive list of compounds, structurally related to
Rottlerin, with antioxidant activity and NFκB inhibitory
properties comprises Drummondins [23], Flavonoids [24],
Resveratrol [25], Genistein [26, 27], Epigallocatechin-3-
Gallate [28], and Curcumin [29].
Although it could have been deduced from the Rottlerin
structure (known at least since 1994), only recently antioxi-
dantpropertiesofRottlerinhavebeenstartedtobedescribed
[30].
In the current paper, we demonstrate that Rottlerin has
antioxidantpropertiesandthattheobservedinhibitoryeﬀect
on NFκB might be the result of Rottlerin hydrogen donating
ability and free radical scavenger activity, in addition to
its biological inhibition of signaling molecules. We also
provide evidence that Rottlerin inhibits NFκBa c t i v a t i o ni n
MCF-7 and HT-29 cells and transcriptional activity in cells
transfected with the NFκB-driven plasmid pBIIX-LUC.
2.MaterialsandMethods
2.1. Materials. Minimum Essential Medium (MEM), fetal
bovineserum(FBS),antibiotics,dimethylsulfoxide(DMSO),
Na-Pyruvate and L-glutamine and 1,1-Diphenyl-2-picryl-
hydrazyl (DPPH), and menadione were purchased from
Sigma (Milan, Italy), dihydrorhodamine 123 (DHR-123)
from Invitrogen, geneticin (G418 sulfate) from Alexis (San
Diego, CA), Rottlerin from Calbiochem (Milan, Italy).
2.2. Cells and Culture Conditions. MCF-7 and TH-29 cells
were purchased by Istituto Zooproﬁlattico Sperimentale
della Lombardia e dell’Emilia-Romagna, Brescia, Italy. MCF-
7 cells were grown in humidiﬁed atmosphere (95% air/
5% CO2)a t3 7
◦C in minimum essential medium (MEM)
containing 10% FBS, Na-Pyruvate (1mM), and antibiotics.
HT-29 cells were grown in Dulbecco’s minimum essential
medium (DMEM) with 10% FBS, glutamine (2mM), and
antibiotics. After reaching subconﬂuence, cells were incu-
bated in serum-free medium for 24 hr and then subjected
to treatments in 2.5% FBS.
2.3. Cell Treatments. MCF-7 and HT-29 cells, pretreated
with or without 20μM Rottlerin for 30min, were stimulated
with 10ng/mL TNFα for 4hr. As to concern the vitamin E
samples, 24hr preincubation time with 50μM α-tocopherol
(dissolved in DMSO at the ﬁnal concentration in the cells
of 0.1%) was selected on the basis of uptake experiments
performed on cells (data not shown).
2.4.ElectrophoreticMobilityShiftAssay(EMSA). EMSAassay
was performed as previous described by Valacchi et al.
2005 [31]. MCF-7 and HT-29 cells were plated on 100-
mm dishes (7.5 × 105cells/dish) and treated as described
above. Cells were washed three times with ice-cold PBS,
and dishes placed on dry ice/ethanol. Cells were lysed in
500μl/dish buﬀer A (10mM HEPES, pH 7.9, 10mM KCl,
0.2mM EDTA, 0.1mM EGTA, 1mM DTT, 1mM PMSF,
1mM leupeptin) and transferred to microcentrifuge tubes.
After incubation for 10min on ice, Nonidet P-40 (ﬁnal
concentration 0.02%) was added, and suspensions were
passed six times through a 26.5G needle to optimize cell
lysis. Nuclei were pelleted by centrifugation for 2min at
10,000rpm, and supernatant (cytoplasmic extract) fractions
werecollected.Thenuclearpelletwasresuspendedin50μlo f
buﬀer B (20 mM HEPES, pH 7.9, 0.4M NaCl, 1mM EDTA,
1mM DTT, 1mM PMSF, 1mM leupeptin), incubated for
30minonice,andcentrifugedfor5minat10,000rpmat4◦C
to obtain clear supernatant fractions (nuclear extract). NFκB
consensus oligonucleotide (5 -AGT TGA GGG GAC TTT
CCC AGG C-3 ), NFκBm u t a n to l i g o n u c l e o t i d e( 5  -AGT
TGA GGC GAC TTT CCC AGG C-3 ), and NF-IL6 (consen-
sus) (nonspeciﬁc competitor - 5 -GGAGAGATTGCCTGAC-
GTCAGAGAGGCA-3 ) (Santa Cruz Biotechnology) were
labeled with digoxygenin (Dig) using a DIG Genius gel
shift kit (Boehringer Mannheim, Indianapolis, IN, U.S.A.)
and incubated overnight at 5◦Cw i t hn u c l e a re x t r a c t( 2 0μg
of protein). The complexes were electrophoresed (0.5 Tris-
borate-EDTA buﬀer, 150V for 2hr at room temperature) on
Novex 6% nondenaturing polyacrylamide gels (Invitrogen)
andelectroblotted(400mAfor1hr)inasandwichprocedure
onto nitrocellulose (protein) and nylon (oligonucleotide)Journal of Biomedicine and Biotechnology 3
membranes. The Dig-labeled oligonucleotide was detected
by anti-Dig alkaline phosphatase-conjugated Fab fragments
and enhanced chemiluminescence. The p50 subunit of
NFκBo nt h en i t r o c e l l u l o s em e m b r a n ew a sp r o b e db y
rabbit anti-NFκB (p50) antibody and detected by ECL
Plus.
2.5. N,N-diphenyl-N-picrylhydrzyl (DPPH) Radical Scaveng-
ing Activity. To evaluate the anti-oxidant activity of Rott-
lerin, the model of scavenging the stable free radical DPPH
by hydrogen donating compounds was used.
Asstocksolutions,20μMDPPH(A)and10μMRottlerin
(B), were prepared in absolute ethanol and mixed by adding
increasing volumes of the Rottlerin solution to that of DPPH
in a ﬁnal volume of 3ml to obtain DPPH/Rottlerin molar
ratios 10 : 1, 4 : 1, and 2 : 1. The reaction mixtures
were shaken vigorously and kept in the dark for 30min.
The absorbance of the remaining DPPH was determined at
516nm by UV/Vis Kontron 941 spectrophotometer.
For electron paramagnetic resonance (EPR) spec-
troscopy, the same DPPH/Rottlerin solutions were trans-
ferred to glass capillary tubes and then placed in the
EPR cavity of a Varian E4 ESR spectrometer for spectral
measurements.
2.6. ROS Measurement by FACS Analysis. Serum starved
MCF-7 cells were pretreated with Rottlerin (5 and 20μM)
for 1hr. The cells were loaded with 10μM DHR-123 for 15
minutes, washed by Hanks’ Balanced Salt Solution (HBSS),
and treated by the oxidative stress inducer, menadione
(100μM), or H2O2 (100μM) for 30min in HBSS. The
reaction was stopped by cooling on ice for 1min, and the
cells were immediately analyzed by ﬂow cytometry (BD
FACSCalibur,excitation:488nmlaser,emission:530/30nm).
The level of ROS was indicated by median of DHR-123
ﬂuorescence. Debris and dead cells were discriminated from
the analysis using FSC versus SSC gating.
2.7. Luciferase Reporter Construct and Stable HT-29 Cell
Transfection. The reporter construct pBIIX-LUC was kindly
donated by Dr. Kalle Saksela (Institute of Molecular
Medicine, University of Tampere, Finland). The NF-κB-
driven plasmid pBIIX-LUC was constructed by inserting
a synthetic fragment with two copies of the sequence
ACA GAG GGG ACT TTC CGA GAG separated by four
nucleotides (ATCT) in front of the mouse fos promoter in
plasmid pfLUC [18].
The reporter plasmid was cotransfected with pSV2neo
neomycin-resistance plasmid into HT-29 (ATCC) cells using
electroporation (Bio-Rad Laboratories, Inc.; Hercules, CA).
Brieﬂy, approximately 1 × 107 c e l l sw e r em i x e dw i t h2 0μg
of reporter plasmid and 2μg of pSV2neo plasmid, and
electroporated (275V, 950μF, 2x pulse). Subsequently, the
cells were seeded on a 100 × 20mm dish (TPP) with a
feeder of HT-29 cells treated with mitomycin-C. Neomycin-
resistant clones were selected in 300 μg/mL of geneticin. The
clones containing the reporter plasmid were conﬁrmed by
luciferase activity assay.
2.8. HT-29Cell Treatment and Luciferase Activity Assay.
Stably transfected cells were seeded in 12-well plates and
treated, 24hr later, with Rottlerin for 30min followed by
TNFα (10ng/mL) for 4hr. After the treatment, cells were
rinsed with PBS and then lysed with 100μlo fr e a g e n t
(Luciferase Assay System; Promega Corp., Madison, WI).
Fifty μl of the extracts was mixed with 50μlo fl u c i f e r a s e
substrate, and luminescence was quantiﬁed by luminometer.
2.9. Statistical Analysis. Results are reported as means ±
SEM. Statistical analysis was performed by using Student’s
t-test. P<. 05 was considered statistically signiﬁcant.
3. Results
3.1. Rottlerin Inhibits TNFα-Induced NFκBB i n d i n gA c t i v i t y
in MCF-7 and HT-29 Cells. As shown in Figure 2,n u c l e a r
extracts from nonactivated MCF-7 and HT-29 cells (C)
containedabasalorconstitutiveNFκB/DNAbindingactivity
which was not aﬀected by 20μM Rottlerin treatment (R) nor
by Vitamin E supplementation (V). Vitamin E was chosen as
control since it is a well-known liposoluble antioxidant with
the ability to inhibit NFκB .T r e a t m e n tw i t h1 0n g / m lT N F α
(T) caused an elevated level of NFκB/DNA binding and the
pretreatment of cells with Rottlerin or Vitamin E (T+R and
T+V) inhibited TNFα-induced NFκB/DNA binding. The
unlabeled NFκB consensus oligomer was used as the speciﬁc
competitor and unlabeled NF-IL6 consensus oligomer as the
nonspeciﬁc competitor.
3.2.AntioxidantActivityofRottlerin:ReactionwithDPPH. In
the case of the UV measurements, the DPPH and Rottlerin
spectradonotoverlapandthecompletedisappearanceofthe
typical absorption of DPPH at 514nm was observed when
equal volume of the DPPH and Rottlerin solutions, A and
B, respectively, were mixed (Figure 3). Similar results were
obtained by EPR, which directly measures the free radical
concentration; by mixing the two solutions into the EPR
cavity, the typical EPR signal of DPPH disappeared when
equal volumes of the reagents solutions were mixed, that is
in a 2 : 1 molar ratio (Figur 4), because two molecules of
DPPH are reduced by one molecule of Rottlerin.
3.3. ROS Scavenging Activity of Rottlerin. As shown in
Figure 5,b o t h5a n d2 0μM Rottlerin signiﬁcantly decreases
MCF-7 basal ROS levels and largely prevent ROS generated
by a 30-min treatment with either 100μMH 2O2 or 100μM
menadione.
3.4. Eﬀect of Rottlerin on NFκBA c t i v a t i o ni nH T - 2 9T r a n s -
fectedCells. Asshownin Figure 6, Rottlerin pretreatmentfor
30min prevented activation of NFκB in a dose-dependent
manner,bothbasalandaftera4hrTNFαtreatmentinHT-29
cells transfected with the NFκB-driven plasmid pBIIX-LUC.
These results conﬁrm that Rottlerin is a general inhibitor
of NFκB nuclear migration and transcriptional activity.4 Journal of Biomedicine and Biotechnology
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Figure 2: Rottlerin inhibits TNFα-induced NF-κB/DNA binding activities in MCF-7 and HT-29 cells. Cells were pretreated with Rottlerin
(20μM) or with Vitamin E (50μM) with subsequent stimulation with TNFα (10ng/mL) for 4hr . Nuclear extracts (20μg) were used
to determine NF-B DNA binding activities by electrophoretic mobility shift assay (EMSA) using DIG-labled oligonucleotide containing
NFκB element. The unlabeled NFκB consensus oligomer was used as the speciﬁc competitor and unlabeled NF-L6 consensus oligomer
as the nonspeciﬁc competitor. Bottom panel shows the bands quantiﬁcation of a representative blot. Complexes were visualized by

















Figure 3: UV spectra of DPPH/Rottlerin solutions in absolute
ethanol. (a) 20μM DPPH ethanol solution (A); (b) spectrum of the
mixture DPPH/Rottlerin obtained by mixing 2.5ml of solution A
with 0.5ml of solution B (10 : 1 molar ratio); (c) 2.0ml of solution
Awith1mlofsolutionB(4 : 1molarratio);(d)1.5mlofsolutionA
with 1.5ml of solution B (2 : 1 molar ratio); (e) spectrum of 10μM
Rottlerin ethanol solution (B).
4. Discussion
DPPH is a stable free radical, which is widely used to test
the hydrogen donation of antioxidants [33]. Recently, the
abilityofRottlerintoscavengeDPPHincomparisontoother
phenolic phytochemicals has been described. Empirically
established concentrations of phytochemicals and DPPH
showed that the Rottlerin scavenging ability was lower than
thatofresveratrolandgenistein,higherthanthatofquercetin
andepigallocatechingallate,androughlyofthesameorderof
that of curcumin [30].
In the present study, in order to further evaluate the
hydrogen donation power of Rottlerin, we reacted one
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Figure 4: EPR spectra of DPPH /Rottlerin solutions in absolute
ethanol. (a) 20μM DPPH ethanol solution (A); (b), (c), and (d)
correspond to the (b), (c), and (d) solutions of Figure 2.A l ls p e c t r a
were recorded in the same experimental conditions.
followed the reaction by UV measurement and EPR spec-
troscopy (Figures 2 and 3). This last reaction is thermody-
namically supported by the fact that the Bond Dissociation
Enthalpy of the N-H group of the reduced DPPH is
80Kcal/mol [34] and that of the O-H group of Vit-E is
77.9Kcal/mol [35]. On the basis of this data it may be
assumed that the hydrogen donation power of Rottlerin is
of the same order of that of Vit-E, which is recognized like
the best antioxidant for lipid systems [36].
The radical scavenging ability of polyphenols depends
mainly on the positioning of the O-H groups rather
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Figure 5: Rottlerin prevents both basal and induced intracellular
production of H2O2. MCF-7 cells were pretreated with 5 and
20μM Rottlerin for 1hr and loaded by H2O2-speciﬁc ﬂuorescent
probe DHR-123. Cells were treated with menadione (100μM) and
hydrogen peroxide (100μM) for 30min and analyzed using ﬂow
cytometry.
Rottlerin, which possesses ﬁve phenolic O-H all conjugated
to the same −CH2− group. This may suggest a higher
antioxidant activity than that of the two frequently used
ROS scavengers, namely, butylated hydroxyanisole (BHA)
and butylatedhydroxytoluene (BHT), which show BDEs of
81.1 and 79.1Kcal/mol, respectively [38].
Because DPPH is an artiﬁcial radical and may not
reproduce the in vivo situation, we also tested the Rott-
lerin antioxidant properties on cultured cells. According to
the DPPH radical-reducing activity and its fast reactivity,
Rottlerin neutralized hydrogen peroxide added to the cells
and prevents free radicals generation (Figure 4). These
ﬁnding are consistent with our previous report showing
that Rottlerin quickly inhibited NFκBa c t i v a t i o nt r i g g e r e db y
hydrogen peroxide in HaCaT keratinocytes [11]a n da r ei n
accordancewiththestudybyLongpreandLoo[30],showing
that 20μM Rottlerin prevented deoxycholate-induced ROS
generation in HCT-116 cells.
Rottlerin-mediated inhibition of NFκBi sn o tr e s t r i c t e d
to PMA [10] and hydrogen peroxide [11] because it also
blunts TNFα-mediated NFκB activation. The current study
indeed showed that NFκB nuclear migration and transcrip-
tional activity, both basal and after stimulation by TNFα,
are strongly inhibited by the drug in native MCF-7 cells and
in HT-29 cells, and in HT-29 transfected with the NFκB-
drivenplasmidpBIIX-LUC,(2).Ourresultsalsoparallelwith
a study by Zhang et al. where has been shown that Rottlerin
inhibits NFκB activation in MCF7 sensitized cells to TRAIL-
induced apoptosis [39].
Taking in account the current results and previous data
on PMA-stimulated MCF-7 cells [10]a n dH 2O2-stimulated-
















Figure 6: Eﬀect of Rottlerin on NFκB nuclear translocation and
transcriptional activity in HT-29 transfected cells. HT-29 cells,
stably transfected with the NFκB-driven plasmid pBIIX-LUC, were
p r e t r e a t e df o r3 0m i nw i t h5a n d2 0 μM Rottlerin and then
treated with 10ng/mL TNFα for 4hr, before luciferase activity
measurement. Data are the mean value ± SD of four independent
experiments.
a general inhibitor of NFκB regardless of the activation
pathway (PMA, oxidative stress or TNFα) and the cell type
(MCF-7, HaCaT, HT-29 cells).
By integrating these ﬁndings, we conclude that the
inhibitory eﬀect of Rottlerin on NFκB is likely the result
of a convergent double activity, free radical scavenging, and
inhibition of key molecules, such as CaMKII [10] and/or
PKC [40, 41] involved in the NFκB activation process.
Activation of NFκB is regulated by a bewildering number
of signaling pathways, the contribution of which, in particu-
lar the cascade that mediates oxidative stress-induced NFκB,
is not always known in detail. The only target common to
the several positive or negative signals to NFκB is the IKK
complex, but this, representing the ﬁnal converging step of
the diﬀerent cascades, does not give information on the
upstream mediators.
It is likely that Rottlerin acts at a step in which all the
stimuli used (PMA, H2O2, menadione, TNFα)c o n v e r g ei n
the signal transduction pathway leading to NFκB activation.
It has been reported that 100μMR e s v e r a t r o lb l o c k s
NFκB activation through inhibition of the upstream PKC
δ/PKD cascade in HeLa cells [41]. Since Rottlerin, at doses
between 5 and 20μM, is a PKCδ inhibitor, we initially
thought that the Resveratrol’s mechanism of action could
explain also the Rottlerin eﬀects on NFκB in MCF-7 cells.
However, a preliminary experiment showed that 20μM
Rottlerin did not inhibit PMA-stimulated PKD phosphory-
lation on Ser 744 and Ser 748 (unpublished observation),
indicating that Resveratrol and Rottlerin, although both are
antioxidant with similar potency [30]a n dP K Cδ inhibitors,
act with diﬀerent mechanisms in NFκB inhibition.6 Journal of Biomedicine and Biotechnology
As far as the Rottlerin antioxidant eﬀect is concerned,
the interference of other natural antioxidants in the NFκB
activation process has been already described. For example,
mangiferin, a natural polyphenol with antioxidant proper-
ties, and melatonin, another potent antioxidant, block TNF-
induced NFκBa c t i v a t i o n[ 42, 43].
In closing, the antioxidant eﬀect of Rottlerin surely plays
a main role in the NFκB activation process triggered by PMA
or H2O2 or menadione or TNFα, but further studies will
be necessary to establish the relative contribution of the two
(chemicalandbiological)mechanismsandtoclarifywhether
they act in parallel or in interdependent ways.
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